AIM
ONC

Aigen Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Aigen Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,957
Closed -$1.35M – 1122
2025
Q1 		$1.35M Buy
4,957
+2,242
+83% +$524K 0.22% 141
2024
Q4 		$501K Buy
+2,715
New +$555K 0.09% 330
2024
Q1 		– Sell
-1,635
Closed -$295K – 1066
2023
Q4 		$295K Buy
+1,635
New +$296K 0.05% 493
2023
Q2 		– Sell
-2,335
Closed -$503K – 1005
2023
Q1 		$503K Buy
+2,335
New +$560K 0.07% 310
2022
Q1 		– Sell
-703
Closed -$201K – 1166
2021
Q4 		$201K Buy
+703
New +$237K 0.01% 934
2021
Q1 		– Sell
-5,684
Closed -$1.47M – 931
2020
Q4 		$1.47M Buy
+5,684
New +$1.56M 0.19% 136

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aigen Investment Management's ONC Position: Q2 2025 in Review

Aigen Investment Management sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 4,957 shares — an estimated $1.35M sold.

Aigen Investment Management first reported a position in ONC in Q4 2020 and held it in 6 quarters. The position peaked at $1.47M in Q4 2020. 244 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Aigen Investment Management reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Aigen Investment Management sold 4,957 BeOne Medicines Ltd shares in Q2 2025, an estimated $1.35M.
  • Aigen Investment Management first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 6 quarters.
  • Aigen Investment Management's BeOne Medicines Ltd position peaked at $1.47M in Q4 2020.
  • 244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Aigen Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.